KEWAUNEE SCIENTIFIC CORP /DE/·4

Jun 25, 4:34 PM ET

Ranade Mandar 4

4 · KEWAUNEE SCIENTIFIC CORP /DE/ · Filed Jun 25, 2026

Research Summary

AI-generated summary of this filing

Updated

Kewaunee Scientific (KEQU) SVP Ranade Mandar Receives 2,635-Share Award

What Happened
Ranade Mandar, Senior Vice President of IT & Engineering at Kewaunee Scientific (KEQU), received a grant of 2,635 restricted stock units (RSUs) on 2026-06-24. The RSUs are recorded as a derivative award with a grant price of $0.00 (no cash purchase); the filing shows an acquisition code "A" for award/grant.

Key Details

  • Transaction date: 2026-06-24; Form 4 filed: 2026-06-25 (timely filing).
  • Instrument: 2,635 restricted stock units (RSUs); grant price reported $0.00 (derivative award).
  • Vesting: RSUs vest in three equal annual installments beginning June 30, 2027, subject to continued employment (per footnote).
  • Shares owned after transaction: not specified in this Form 4 filing.
  • Transaction code: A = Award/Grant. Footnotes: (1) each RSU equals a contingent right to one share; (2) vesting schedule as above.

Context
RSU grants are a common form of equity compensation for executives and typically represent future share compensation subject to vesting conditions rather than an immediate market purchase or sale. This award does not by itself indicate buying or selling pressure on the stock; shares will only be issued (and become owned) if and when the RSUs vest and are settled.

Insider Transaction Report

Form 4
Period: 2026-06-24
Ranade Mandar
SVP, IT & Engineering
Transactions
  • Award

    Restricted Stock Units FY27

    [F1][F2]
    2026-06-24+2,6352,635 total
    Common Stock (2,635 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F2]The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.
Signature
/s/ Donald T. Gardner III, Attorney-in-fact|2026-06-25

Documents

1 file
  • 4
    wk-form4_1782419685.xmlPrimary

    FORM 4